IR-Med fires CEO, lays off 7 of 10 employees, limits operations amid financial difficulties

IR-Med, Inc.

Board terminated CEO Tzur Di-Cori effective immediately; no disagreement cited.
Company notified 7 of its 10 employees of termination due to financial difficulties.
Effective termination dates range from March 22 to April 22, 2024 based on notice periods.
Board limited operations until sufficient funds are identified to support operations.

item 5.02 item 8.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Tzur Di-Cori

Chief Executive Officer

IR-Med, Inc.

Effective: 2024-02-22
Filed: February 28, 2024, 6:59 PM ET

On February 22, 2024, the board of directors (the “Board”) of IR-Med, Inc. (the “Company”) terminated the employment of Tzur Di-Cori pursuant to which he ceased serving as the Company’s Chief Executive Officer, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Tzur Di-Cori was terminated as Chief Executive Officer at IR-Med, Inc..

Action: terminated
Role: Chief Executive Officer

Exact text from the filing

On February 22, 2024, the board of directors (the “Board”) of IR-Med, Inc. (the “Company”) terminated the employment of Tzur Di-Cori pursuant to which he ceased serving as the Company’s Chief Executive Officer, effective immediately.

View on SEC.gov

Source: SEC EDGAR

accession 0001493152-24-008175

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.